Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.4 USD | -2.67% | +1.69% | +67.33% |
05-09 | ImmunityBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-07 | ImmunityBio Shares Rise After Completion of Drug Substance Manufacturing for Cancer Treatment | MT |
Business Summary
Number of employees: 628
Managers
Managers | Title | Age | Since |
---|---|---|---|
Richard Adcock
CEO | Chief Executive Officer | 55 | 20-09-30 |
Founder | 71 | 14-11-30 | |
David Sachs
DFI | Director of Finance/CFO | 46 | 19-06-30 |
Leonard Sender
COO | Chief Operating Officer | - | 20-02-29 |
John Lee
CTO | Chief Tech/Sci/R&D Officer | 56 | 19-02-28 |
Sandeep K. Reddy
CTO | Chief Tech/Sci/R&D Officer | - | 20-07-31 |
Hans Klingemann
CTO | Chief Tech/Sci/R&D Officer | 74 | - |
Enrique Dilone
CTO | Chief Tech/Sci/R&D Officer | 57 | 23-08-13 |
Barry Simon
BRD | Director/Board Member | 69 | 06-12-31 |
- | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 71 | 14-11-30 | |
Cheryl L. Cohen
BRD | Director/Board Member | 58 | 19-05-31 |
Wesley Clark
BRD | Director/Board Member | 78 | 21-02-23 |
Director/Board Member | 69 | 20-07-31 | |
Barry Simon
BRD | Director/Board Member | 69 | 06-12-31 |
Michael Blaszyk
BRD | Director/Board Member | 71 | 15-06-30 |
Richard Adcock
CEO | Chief Executive Officer | 55 | 20-09-30 |
John Brennan
BRD | Director/Board Member | 67 | 21-02-23 |
Linda Maxwell
BRD | Director/Board Member | 50 | 21-03-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 691,731,761 | 154,643,815 ( 22.36 %) | 163,800 ( 0.0237 %) | 22.36 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+67.33% | 5.97B | |
+5.33% | 111B | |
+12.11% | 105B | |
-12.56% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.86% | 16.96B | |
+5.10% | 13.7B | |
+37.57% | 12.45B |
- Stock Market
- Equities
- IBRX Stock
- Company ImmunityBio, Inc.